Creation of MyoPowers, company specialized in the development of artificial muscles for the treatment of severe incontinence.
Capital increase for Epygon for an amount of €1,240,000 subscribed mainly by funds generated by Truffle Capital.
Kalios™ and Epygon enter into in-vivo preclinical phase (animal).
Recent Comments